CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
iTBS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04936594
NCT04936594N/ACompleted
CompareCT.gov

Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA)

Gopalkumar Rakesh·interventional·Posted Jun 23, 2021·Updated Jul 13, 2023

In Brief

A clinical study evaluating iTBS and TMS for Smoking Cessation and 2 related conditions. Completed, enrolled 9 participants across 1 site.

Detailed Summary

The pilot study proposal aims to modulate craving and attentional bias towards smoking cues in 40 people living with HIV/AIDS (PLWHA) using transcranial magnetic stimulation (TMS), with functional MRI (fMRI) brain correlates. TMS is a form of noninvasive brain stimulation and modulates neural activity using tiny doses of focused electricity. For the study, participants would perform two cognitive tasks and neuroimaging before and after the TMS and investigators would compare changes in these paradigms with TMS. The investigators will also get a point of contact urine drug screen before study initiation. The investigators will aim to recruit 20 subjects in each arm of our trial (total of 40) from the BlueGrass HIV Clinic.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation, HIV, Craving
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJun 23, 2021
Enrollment StartMay 24, 2021
Primary CompletionNov 24, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5.0 years ago

Interventions

iTBSdevice

1800 pulses of iTBS

TMSdevice

MagVenture MagPro x100 device. This will be used as the comparator.